Inicio>>Lipids>> Prostaglandins>>5-trans Fluprostenol isopropyl ester

5-trans Fluprostenol isopropyl ester (Synonyms: 5,6trans Fluprostenol isopropyl ester, 5trans Travoprost)

Catalog No.GC41590

Travoprost is the Alcon trade name for fluprostenol isopropyl ester, an F-series prostaglandin analog which has been approved for use as an ocular hypotensive drug.

Products are for research use only. Not for human use. We do not sell to patients.

5-trans Fluprostenol isopropyl ester Chemical Structure

Cas No.: 1563176-59-9

Tamaño Precio Disponibilidad Cantidad
1mg
122,00 $
Disponible
5mg
548,00 $
Disponible
10mg
973,00 $
Disponible
50mg
3.892,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Travoprost is the Alcon trade name for fluprostenol isopropyl ester, an F-series prostaglandin analog which has been approved for use as an ocular hypotensive drug. Fluprostenol isopropyl ester is a prodrug which is converted by esterase enzymatic activity in the cornea to yield the corresponding free acid. 5-trans Fluprostenol isopropyl ester (5-trans Travoprost) is an impurity that is routinely found in bulk preparations of fluprostenol isopropyl ester in amounts ranging from 1-3%. The pharmacology of 5-trans fluprostenol isopropyl ester has not been studied extensively to date.

Reseñas

Review for 5-trans Fluprostenol isopropyl ester

Average Rating: 5 ★★★★★ (Based on Reviews and 7 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for 5-trans Fluprostenol isopropyl ester

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.